The Pediatric Cancer Research Foundation (PCRF), a national nonprofit
focused on funding leading-edge research to end childhood cancers, today
announced a major award for Burkitt’s Lymphoma research. Called the Cody
Camp Fellowship in Burkitt’s Lymphoma Research, the grant honors a
six-year-old boy who lost his battle with the disease.
Burkitt’s Lymphoma is the most common form of non-Hodgkin lymphoma among
five- to 14-year-old children1. While it is a highly
aggressive cancer that is often life threatening, it is also one of the
more curable forms of non-Hodgkin lymphoma2.
The Cody Camp Fellowship in Burkitt’s Lymphoma Research is presented by
Cody’s parents, Patricia and Donald Camp of Colchester, CT. It awards
$300,000 over the next five years to support the work of Dr. Sanghoon
Lee, PhD, MSc in the Division of Pediatric Oncology and Hematology of
the Maria Fareri Children’s Hospital at Westchester Medical Center. Dr.
Lee’s work specifically focuses on the genetic basis of Burkitt Lymphoma
and the genetic and proteomic mechanisms of resistance.
“Cody was a very determined little boy who loved playing and watching
baseball and especially the Red Sox. We could think of no better way to
honor him than by funding research that can help other children
successfully defeat their cancer and lead long, healthy and productive
lives,” said Patricia Camp.
“At a time when funds for pediatric cancer research are declining, we
are grateful to the Camps for their incredible generosity and recognize
how their gift is both remarkable and purpose-filled,” said, Jeri
Wilson, executive director of PCRF. “I know Dr. Lee and his colleagues
will strive every day to ensure their research delivers the major
homeruns that Cody and others like him so richly deserve.”
The need for pediatric cancer research dollars is at an all-time high.
Cancer is currently the leading cause of death by disease in children in
the United States.3 Each year cancer kills more children than
asthma, diabetes, cystic fibrosis, congenital anomalies and acquired
immunodeficiency syndrome combined.4 Yet, the National Cancer
Institute (NCI), the federal government’s principal agency for cancer
research, allocates less than five percent of its annual budget5 for
childhood cancer research and private sector funding has been limited to
the philanthropic efforts of foundations, businesses and concerned
About Pediatric Cancer Research Foundation (PCRF)
The Pediatric Cancer Research Foundation (PCRF) is an independent,
nonprofit organization, wholly dedicated to funding leading-edge
pediatric cancer research nationwide. Since its founding in 1982, PCRF
has raised over $30 million dollars towards the ultimate goal of ending
pediatric cancers so children and their families can re-focus on the
joys of childhood. This commitment has translated into immediate
treatment for children with cancer by developing innovative treatment
protocols; improving patients’ long-term quality of life; and supporting
those scientists working on the precipice of important medical
breakthroughs. For more information, please visit www.PCRF-kids.org.